Assignee
SHANGHAI ENNOVABIO PHARMACEUTICALS CO LTD
CN·4 granted patents·3 pending applications·0 citations·filing 2018–2019
Top patents by PatentIndex Score
7 records- 0147US12258336B2Preparation of seimicarbazide-sensitive amine oxidase inhibitor and use thereofSHANGHAI ENNOVABIO PHARMACEUTICALS CO LTD·Filed 2019·Granted Mar 25, 2025·0 cites·10 claims
- 0241US12234232B2Aromatic heterocyclic compound with kinase inhibitory activitySHANGHAI ENNOVABIO PHARMACEUTICALS CO LTD·Filed 2019·Granted Feb 25, 2025·0 cites·9 claims
- 0340US12391687B2Five-and-six-membered heterocyclic compound and use thereof as protein receptor kinase inhibitorSHANGHAI ENNOVABIO PHARMACEUTICALS CO LTD·Filed 2019·Granted Aug 19, 2025·0 cites·8 claims
- 0440US2022017512A1Six-membered and six-membered heterocyclic compound and uses thereof serving as protein receptor kinase inhibitorSHANGHAI ENNOVABIO PHARMACEUTICALS CO LTD·Filed 2019·Application pending·0 cites
- 0540US2021347785A1Preparation and application of aromatic compound having immunoregulatory functionSHANGHAI ENNOVABIO PHARMACEUTICALS CO LTD·Filed 2019·Application pending·0 cites
- 0640US2022056023A1Preparation and application of class of n-containing heterocyclic compounds having immunoregulatory functionSHANGHAI ENNOVABIO PHARMACEUTICALS CO LTD·Filed 2019·Application pending·0 cites
- 0735US11787766B2Compound having PD-L1 inhibitory activity, preparation method therefor and use thereofSHANGHAI ENNOVABIO PHARMACEUTICALS CO LTD·Filed 2018·Granted Oct 17, 2023·0 cites·3 claims
Join the waitlist — get patent alerts
Get an alert when SHANGHAI ENNOVABIO PHARMACEUTICALS CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →